Eli Lilly and Company Announces European Regulatory Submission for Gemzar for the Treatment of Breast Cancer.

Extract


Eli Lilly and Company Announces European Regulatory Submission for Gemzar for the Treatment of Breast Cancer.

Business Editors, Health & Medical Writers

INDIANAPOLIS--(BUSINESS WIRE)--Dec. 12, 2002

Eli Lilly and Company announced i...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company